Multicenter Worksite Nutrition Study (WNS2)

The purpose of this study is to study the potential benefits of low fat vegan diet in a randomized, controlled and multi-centered workplace setting, the investigators will enroll participants from 10 worksites of Government Employee Insurance Company (GEICO). After randomization, 5 will be the vegan sites and 5 will be the control sites for 10 month study. The vegan sites will receive low fat vegan diet instructions and weekly group sessions starting from year 1. no intervention is done to the control sites until the week 18 when the identical program will be given. At various time points, health measurements will be give to all participants.

Study Overview

Detailed Description

The purpose of this study is to study the weight loss and other potential benefits of low fat vegan diet as compared to the standard American diet in a randomized, controlled and multi-centered workplace setting.

The 10 months study involves 5 vegan sites and 5 control sites generated through a random process after recruitment. The vegan sites will receive low fat vegan diet instructions and weekly group sessions starting from the January, 2011. The control sites will also receive identical instructions starting from the 5th month and lasting for 18 weeks.

For each participant at baseline and week 18 a blood test will be conducted, along with blood pressure, weight, hip and waist measurements. A questionnaire will also be administered during these time points to assess dietary intake, work productivity, quality of life, and healthcare utilization. At the end of one year, information about health insurance utilization will be obtained from Health Maintenance Organization(HMO) or Preferred Provider Organization(PPO) for each participant.

Study Type

Interventional

Enrollment (Actual)

292

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Arizona
      • Tucson, Arizona, United States, 85710
        • Tucson
    • California
      • San Diego, California, United States, 92064
        • San Diego
    • Florida
      • Lakeland, Florida, United States, 33811
        • Lakeland
    • Georgia
      • Macon, Georgia, United States, 31295
        • Macon
    • Maryland
      • Chevy Chase, Maryland, United States, 20815
        • Chevy Chase
    • New York
      • Buffalo, New York, United States, 14068
        • Buffalo
      • Woodbury, New York, United States, 11797
        • Woodbury
    • Texas
      • Dallas, Texas, United States, 75244
        • Dallas
    • Virginia
      • Fredericksburg, Virginia, United States, 22412
        • Fredericksburg
      • Virginia Beach, Virginia, United States, 23454
        • Virginia Beach

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 70 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Paid employee at a participating GEICO worksite for at least 6 months
  • Currently a full-time employee at GEICO working for GEICO (at least 38.75 hours/week)
  • Age of at least 18 years
  • Ability and willingness to participate in all components of the study
  • A willingness to be assigned to the vegan diet group or the control group
  • Body mass index ≥ 25 kg/m2 and/or a diagnosis of type 2 diabetes mellitus, as defined by a fasting plasma glucose concentration ≥ 126 mg/dl on two occasions or a prior physician's diagnosis of type 2 diabetes

Exclusion Criteria:

  • A history of alcohol abuse or dependency followed by any current use
  • Current or unresolved past drug abuse
  • Pregnancy or plans to become pregnant in the next 12 months
  • Intention to leave GEICO in the next 12 months
  • History of severe mental illness
  • Unstable medical status
  • Already following a low-fat, vegetarian diet
  • An inordinate fear of blood draws
  • Previously participated in GEICO two site study

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Supportive Care
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: vegan group
participants from sites of this group will receive vegan nutritional intervention starting from Feb 2011
weekly 1-hr instructions including vegan nutritional information and cooking instructions. vegan menu will be made available at the cafeteria
no intervention in until June 2011. The control group start vegan diet in July 2011.
No Intervention: control group
participants from sites of the control group will not receive the same nutritional information until June 2011

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
weight
Time Frame: 0 months
body weight at baseline
0 months
weight
Time Frame: 18 weeks
body weight at the end of 4 months
18 weeks
weight
Time Frame: 10 months
body weight at the end of 12 months
10 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
blood pressure
Time Frame: 0 months
diastolic and systolic blood pressures at baseline
0 months
blood pressure
Time Frame: 18 weeks
diastolic and systolic blood pressures at the end of 4 months
18 weeks
blood pressure
Time Frame: 10 months
diastolic and systolic blood pressures at the end of 12 months
10 months
waist circumference
Time Frame: 0 month
measurement of waist circumference at baseline
0 month
waist circumference
Time Frame: 18 weeks
measurement of waist circumference at 4 months
18 weeks
waist circumference
Time Frame: 10 months
measurement of waist circumference at 12 months
10 months
absenteeism
Time Frame: 0 month
number of days absent because of sickness over the past 6 months, surveyed at baseline
0 month
absenteeism
Time Frame: 18 weeks
number of days absent because of sickness over the past 4 months, surveyed at the end of 4 months.
18 weeks
absenteeism
Time Frame: 10 months
number of days absent because of sickness over the past 6 months, surveyed at the end of 12 months.
10 months
health insurance utilization
Time Frame: 0 month
categorized payments by health insurance company for health-related coverage over the past 12 months, surveyed at baseline
0 month
healthy insurance utilization
Time Frame: 12 months
categorized payments by health insurance company for health-related coverage over the past 12 months, surveyed at the end of 12 months
12 months
blood lipid panel
Time Frame: 0 month
blood test of Low Density Lipoprotein (LDL), High Density Lipoprotein (HDL), total cholesterol, and triglyceride at baseline
0 month
blood lipid panel
Time Frame: 18 weeks
blood test of Low Density Lipoprotein (LDL), High Density Lipoprotein (HDL), total cholesterol, and triglyceride at the end of 4 months
18 weeks
blood lipid panel
Time Frame: 10 months
blood test of Low Density Lipoprotein (LDL), High Density Lipoprotein (HDL), total cholesterol, and triglyceride at the end of 12 months
10 months
quality of life
Time Frame: 0 month
questionnaire on quality of life measurements surveyed at baseline
0 month
quality of life
Time Frame: 18 weeks
questionnaire on quality of life measurements surveyed at the end of 4 months
18 weeks
quality of life
Time Frame: 10 months
questionnaire on quality of life measurements surveyed at the end of 12 months
10 months
hemoglobin A1c
Time Frame: 0 month
blood test of hemoglobin A1c level (for diabetic participants only) at baseline
0 month
hemoglobin A1c
Time Frame: 18 weeks
blood test of hemoglobin A1c level (for diabetic participants only) at the end of 4 months
18 weeks
hemoglobin A1c
Time Frame: 10 months
blood test of hemoglobin A1c level (for diabetic participants only) at the end of 12 months
10 months
hip circumference
Time Frame: 0 month
measurement of hip circumference at baseline
0 month
hip circumference
Time Frame: 18 weeks
measurement of hip circumference at the end of 4 months
18 weeks
hip circumference
Time Frame: 10 months
measurement of hip circumference at the end of 12 months
10 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Neal Barnard, M.D., Washington Center for Clinical Research

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

October 1, 2010

Primary Completion (Actual)

June 1, 2011

Study Completion (Actual)

October 1, 2011

Study Registration Dates

First Submitted

August 30, 2010

First Submitted That Met QC Criteria

October 18, 2010

First Posted (Estimate)

October 20, 2010

Study Record Updates

Last Update Posted (Estimate)

January 24, 2013

Last Update Submitted That Met QC Criteria

January 23, 2013

Last Verified

January 1, 2013

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • WCCR-WNS2

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Diabetes

Clinical Trials on vegan instruction and food accessibility

3
Subscribe